Barclays’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-100
Closed -$3K 6061
2020
Q1
$3K Buy
+100
New +$3.79K ﹤0.01% 5989
2019
Q4
Sell
-8,400
Closed -$351K 6672
2019
Q3
$351K Hold
8,400
﹤0.01% 4531
2019
Q2
$309K Buy
8,400
+2,700
+47% +$98.4K ﹤0.01% 4745
2019
Q1
$218K Sell
5,700
-50,000
-90% -$1.85M ﹤0.01% 4756
2018
Q4
$1.96M Sell
55,700
-121,500
-69% -$4.21M ﹤0.01% 2430
2018
Q3
$5.81M Buy
177,200
+3,700
+2% +$118K ﹤0.01% 1662
2018
Q2
$5.38M Sell
173,500
-14,600
-8% -$417K ﹤0.01% 1669
2018
Q1
$5.09M Sell
188,100
-44,600
-19% -$1.19M ﹤0.01% 1626
2017
Q4
$6.41M Buy
232,700
+10,800
+5% +$312K 0.01% 1473
2017
Q3
$7.08M Buy
+221,900
New +$7.11M 0.01% 1281
2013
Q4
Sell
-147,800
Closed -$4.29M 7633
2013
Q3
$4.29M Buy
+147,800
New +$4.5M 0.01% 1817

Other funds holding OHI

Barclays's OHI Position: Q1 2026 in Review

Barclays reduced its Omega Healthcare (OHI) stake by 39% in Q1 2026, selling an estimated $4.94M and leaving 168,608 shares worth $7.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1606.

Barclays first reported a position in OHI in Q2 2013 and has held it in 52 quarters since. The position peaked at $26.3M in Q2 2025. 740 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • Barclays held 168,608 shares of Omega Healthcare worth $7.39M as of Q1 2026.
  • Barclays sold 108,134 Omega Healthcare shares in Q1 2026, an estimated $4.94M.
  • Omega Healthcare made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1606 holding.
  • Barclays first reported a position in Omega Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Omega Healthcare position peaked at $26.3M in Q2 2025.
  • 740 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.